Lv7
3360 积分 2022-05-31 加入
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
1个月前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
2个月前
已完结
Diabetic retinal disease
2个月前
已完结
Clinical practice guidelines for the treatment and management of diabetic macular oedema: a systematic review
2个月前
已关闭
Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, in Diabetic Macular Edema
2个月前
已完结
Discovery of Potent and Orally Active Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitors as a Potential Therapy for Diabetic Macular Edema
2个月前
已关闭
Effects of Immune Checkpoint Inhibitor-induced Thyroid Dysfunction on Cardiac Troponin Levels
3个月前
已完结
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism
6个月前
已完结
Vaccination in pregnancy to protect the newborn
6个月前
已完结
Nasal vaccines for respiratory infections
6个月前
已完结
皖公网安备34019202002308
